Bettering Me

Category: Body

  • “Vitality Span” Is a Marketing Term. What Matters Is Whether You’re Losing 2% of Your Aerobic Capacity Per Year

    Written by

    Unpaid Intern

    –

    “Vitality span” is one of those terms that sounds meaningful and means nothing. It has no standard definition, no validated measurement protocol, and no clinical utility. It is a marketing tool designed to sell programs, supplements, and subscriptions by making you feel like you are missing something that a product can provide. The concept it gestures toward is real – the difference between living longer and living well – but the packaging obscures the actual mechanism.

    The mechanism is VO2 max.

    VO2 max – the maximum rate at which your body can utilize oxygen during intense exercise – is the single most robust predictor of all-cause mortality in middle-aged and older adults, outperforming every blood biomarker in head-to-head comparisons [1]. The Baltimore Longitudinal Study of Aging demonstrated that the decline begins earlier than most people realize: VO2 max declines approximately 10% per decade after age 30 in sedentary individuals, and the rate of decline accelerates after age 50 [2]. This decline is not optional in the sense that you can prevent it entirely. It is a biological consequence of aging – reduced maximal heart rate, reduced stroke volume, reduced mitochondrial density, reduced capillary density in skeletal muscle, and reduced oxygen extraction by working muscles.

    What is optional is the starting point and the rate of decline.

    A person who reaches age 40 with a VO2 max of 45 mL/kg/min – roughly the 50th percentile for a 40-year-old man – and loses 10% per decade will reach approximately 36 mL/kg/min at age 60 and approximately 29 mL/kg/min at age 70. A person who starts at 35 mL/kg/min – roughly the 20th percentile – will be at 28 mL/kg/min at 60, a level at which simple activities of daily living (walking up stairs, carrying groceries, walking at a moderate pace) begin to require a significant percentage of maximal capacity [1]. Above approximately 30 mL/kg/min, activities of daily living are metabolically comfortable. Below that threshold, the same activities become demanding, fatigue-inducing, and eventually impossible.

    This is the concept that “vitality span” is trying to capture but fails to define: the threshold below which your aerobic capacity limits your freedom. It is not an abstract concept. It is a specific number that you can measure, track, and improve.

    The physiology of VO2 max has two components. The central component is the heart’s ability to deliver oxygenated blood – determined by maximal cardiac output (stroke volume × heart rate). The peripheral component is the muscle’s ability to extract and use that oxygen – determined by mitochondrial density, capillary density, and oxidative enzyme activity. Zone 2 training improves both components, but its primary effect is peripheral: it increases mitochondrial biogenesis and capillary density, improving the muscles’ ability to use oxygen rather than the heart’s ability to deliver it [3]. This is why Zone 2 is the foundation and HIIT is the polish – HIIT improves central function (maximal stroke volume and heart rate) but requires the peripheral base that Zone 2 builds.

    For a 45-year-old who did not build a high aerobic ceiling in their 20s and 30s, the intervention window is not closed, but the strategy changes. Zone 2 training at approximately 65-75% of max heart rate (the “conversational pace” where you can speak in full sentences but not comfortably sing) for 150-200 minutes per week has been shown to improve VO2 max by 10-15% in previously sedentary middle-aged adults over 12-16 weeks [3]. The gains are smaller than what a 25-year-old would achieve with the same protocol, but they are real and clinically meaningful. A 10% improvement in VO2 max at age 45 translates to approximately 5-7 additional years before you cross the functional dependence threshold.

    What does this look like in practice? Three to four sessions per week, each 40-50 minutes at conversational pace. A stationary bike, rower, incline treadmill, or outdoor flat walk. Heart rate at 130-150 bpm for most people (specific range depends on age and resting heart rate). The pace should feel “comfortably hard” – you could sustain it for hours but you would not want to. This is not a race. It is a base-building protocol.

    The question “are you healthy for 40” is the wrong question. The question is “what ceiling did you build in your 20s and 30s” – because that ceiling determines where you land in your 60s and 70s, regardless of what you do now. If you did not build that ceiling, start building it now. The window is narrower, but it is not closed.

    Bettering Me’s position: vitality span is a marketing term. VO2 max ceiling is a physiological fact. Track the ceiling. Build it while the window remains open.

    A note on testing. The gold standard is a maximal cardiopulmonary exercise test (CPET) with gas exchange measurement – a ramp protocol on a treadmill or bike to volitional exhaustion, with a mask collecting expired gases. This costs $200-400 and provides true VO2 max, ventilatory thresholds (VT1 and VT2), and heart rate zones. The practical alternative is a submaximal estimated VO2 max from a 1-mile walk test (Rockport test), a 12-minute Cooper test, or an estimated value from a device like Garmin or Apple Watch. These estimates have a 10-15% error margin but are good enough for trend tracking. If you can afford a CPET once at baseline and then use estimated tests annually, that is the optimal approach.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Myers J, et al. "Exercise capacity and mortality among men referred for exercise testing." *NEJM*. 2002;346(11):793-801.. DOI: https://doi.org/10.1056/NEJMoa011858

    [2] Fleg JL, et al. "Accelerated longitudinal decline of aerobic capacity in healthy older adults." *Circulation*. 2005;112(5):674-682.. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.545459

    [3] Earnest CP, Blair SN, Church TS. "Age progression of the association of maximal oxygen consumption with all-cause mortality." *Med Sci Sports Exerc*. 2014;46(3):536-542.. DOI: https://doi.org/10.1249/MSS.0b013e3182a76c38

  • Frameworks Come and Go. The Three Non-Negotiables Are Sleep, Strength, and Aerobic Base

    Written by

    Unpaid Intern

    –

    Every longevity framework – regardless of the brand, the price tag, the celebrity endorsement, or the proprietary protocol name – collapses to the same three anchors when you strip the marketing layer. The seven-step morning routine becomes consistent wake timing. The custom supplement stack becomes adequate protein intake. The biohacking protocol becomes resistance training. The fancy endurance program becomes aerobic volume above 150 minutes per week.

    Frameworks differentiate themselves because differentiation is the business model. But biology does not care about differentiation. Biology responds to the same inputs regardless of the brand name.

    The first non-negotiable is consistent sleep timing, not just sleep duration.

    The circadian system does not care about your weekend sleep-in. Sleep midpoint variability of more than 60 minutes across the week – meaning your bedtime shifts by more than an hour between work nights and weekends – is associated with worse metabolic health, higher inflammatory markers, poorer cognitive performance, and increased cardiovascular risk, independent of total sleep time [1]. A person who sleeps 7.5 hours but whose bedtime varies by 90 minutes has worse metabolic outcomes than a person who sleeps 7 hours with a consistent bedtime.

    The mechanism is circadian disruption. The suprachiasmatic nucleus – the brain’s master clock – synchronizes peripheral clocks in the liver, muscle, adipose tissue, and pancreas. When sleep timing shifts, these peripheral clocks desynchronize, producing a state of internal jet lag even when total sleep time is adequate. The liver expects food at certain times relative to the sleep-wake cycle. When the sleep window shifts, the liver’s metabolic enzyme expression desynchronizes from feeding timing, producing impaired glucose tolerance, altered lipid metabolism, and increased inflammatory signaling.

    Consistent sleep timing means going to bed within 30 minutes of the same time, seven days a week. It does not mean never staying up late – it means that if you stay up late on Friday, you wake up at your usual time on Saturday rather than sleeping in. The circadian system resets through morning light exposure, not through catch-up sleep.

    The second non-negotiable is resistance training at mechanical load.

    Muscle mass is the single tissue that determines functional independence in later life. The preservation signal requires mechanical tension – load above 70% of your one-rep maximum – not calisthenics, not yoga, not walking. Two sessions per week at sufficient load produces the maintenance signal that prevents sarcopenia [2].

    “Mechanical load” means different things for different body parts. For lower body: squats, deadlifts, lunges, or leg press at a weight that makes the last two reps of each set genuinely hard. For upper body pushing: bench press, overhead press, or push-ups with added weight. For upper body pulling: rows, pull-ups, or lat pulldowns. For core: any exercise that loads the spine under tension (deadlifts, farmer carries, weighted planks) rather than spinal flexion under load (crunches).

    The minimum effective dose is two sessions per week, three sets per major movement pattern, 6-12 reps per set at 70-80% of 1RM. That is approximately 60-75 minutes per week of resistance training. Below that, you are not preserving muscle. You are exercising.

    The third non-negotiable is aerobic volume above 150 minutes per week.

    The dose-response relationship between aerobic exercise volume and cardiovascular mortality risk reduction is one of the most robust findings in exercise epidemiology. The plateau begins around 150 minutes per week of moderate-intensity aerobic activity, and the benefit continues to accumulate up to approximately 300 minutes per week [3]. Below 150 minutes, the cardiovascular risk reduction is present but significantly smaller. Above 300 minutes, the marginal benefit diminishes.

    “Moderate intensity” means approximately 65-75% of max heart rate, or a 3-4 on the 10-point perceived exertion scale – the pace at which you can speak in full sentences but not comfortably sing. This is Zone 2 training. It does not need to be running. Cycling, swimming, rowing, incline walking, or any sustained rhythmic activity at the appropriate heart rate zone qualifies.

    The sequencing matters. Sleep first because it governs the hormonal and circadian architecture that determines whether strength training and aerobic work produce adaptations. Strength second because it preserves the tissue that determines functional independence. Aerobic third because cardiovascular mortality is the primary killer, but a person with adequate muscle mass and poor cardiovascular fitness has a better survival trajectory than the reverse.

    Counterpoint: what about nutrition? Nutrition is not a separate pillar – it is embedded in all three. Sleep timing determines eating timing (the feeding window). Resistance training requires adequate protein intake (1.6 g/kg minimum) to produce the preservation signal. Aerobic training requires adequate carbohydrate availability for sustained output. There is no meaningful health framework in which nutrition is a fourth independent factor – it is the fuel and building material for the three non-negotiables. Eating whole foods, adequate protein, and aligning feeding with circadian timing is the nutritional expression of the three pillars, not a separate protocol.

    Bettering Me’s framework is not a framework. It is a sequence. Fix sleep timing first. Build strength second. Accumulate aerobic volume third. Do these three things for six months before spending a single dollar on anything else. Frameworks come and go because they need to differentiate themselves from the last framework. The three non-negotiables do not change because they are not products. They are biology.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Fekedulegn D, et al. "Sleep timing variability and health." *Sleep*. 2020;43(6):zsz289.. DOI: https://doi.org/10.1093/sleep/zsz289

    [2] Hughes DC, Ellefsen S, Baar K. "Adaptations to Endurance and Strength Training." *Cold Spring Harb Perspect Med*. 2018;8(6):a029799.. DOI: https://doi.org/10.1101/cshperspect.a029799

    [3] Warburton DER, Bredin SSD. "Health benefits of physical activity: a systematic review." *Curr Opin Cardiol*. 2017;32(5):541-556.. DOI: https://doi.org/10.1097/HCO.0000000000000437

  • Muscle Is Not an Aesthetic Asset. It’s the Only Tissue That Directly Determines Whether You Can Live Independently at 80

    Written by

    Unpaid Intern

    –

    The longevity literature consistently shows that muscle mass and grip strength predict all-cause mortality better than any single blood biomarker [1]. The UK Biobank study of nearly 500,000 participants found that each 5 kg decrease in grip strength was associated with a 16% higher risk of all-cause mortality, and the association held across all age groups, all BMI categories, and after adjusting for physical activity levels, smoking, and socioeconomic status [1]. This is not because muscle is magically protective. It is because muscle is the canary in the metabolic coal mine.

    Declining muscle mass signals declining metabolic reserve – the capacity to withstand illness, surgery, or injury without losing function. A person who enters a hospitalization with low lean mass has fewer amino acid reserves to support immune function and tissue repair, and their recovery trajectory is flatter regardless of the quality of medical care. It signals declining hormone sensitivity – particularly insulin and growth hormone signaling pathways that govern tissue repair, protein synthesis, and cellular maintenance [2]. And it signals declining functional capacity – the threshold below which activities of daily living (standing from a chair, carrying groceries, climbing stairs) become metabolically expensive or impossible.

    There is an important distinction between sarcopenia and dynapenia. Sarcopenia is the loss of muscle mass. Dynapenia is the loss of muscle strength and power, which often precedes measurable mass loss because the nervous system component – the ability to recruit motor units effectively – declines first. A person can lose 10-15% of their strength before they lose a detectable amount of muscle mass, which means waiting for a DEXA scan to show lean mass decline is waiting too long. Functional tests – chair stand, gait speed, grip strength – capture dynapenia early.

    Anabolic resistance is the mechanism that makes midlife muscle preservation urgent. As we age, the muscle protein synthetic response to both protein feeding and resistance exercise diminishes [3]. A 30-year-old can trigger maximal muscle protein synthesis with 20 grams of protein per meal. A 65-year-old needs approximately 40 grams to achieve the same response. The same resistance training stimulus produces proportionally less gain per unit of effort. This is not a reason to stop training – it is a reason to start earlier and maintain consistently. The effort-to-gain ratio worsens with age, but the consequences of not training are even worse.

    The sarcopenia diagnostic criteria established by the European Working Group on Sarcopenia in Older People provide a useful reference point, even for prevention: low muscle strength (grip strength below 27 kg for men, below 16 kg for women), low muscle quantity (appendicular lean mass index below 7.0 kg/m² for men, below 5.5 kg/m² for women), and low physical performance (gait speed below 0.8 m/s) [4]. These are clinical thresholds – you do not want to approach them in your 60s, which means your 40s are the construction window.

    The Bettering Me protocol for muscle preservation: a DEXA scan at baseline to establish your lean mass, fat mass, and bone mineral density. Repeat every two years to track trajectory. Two resistance sessions per week at 70-80% of 1RM for compound movements. Protein at 1.6 g/kg minimum, distributed across three to four meals. Grip strength measured annually as a compliance check – if it drops more than 5 kg from baseline, your training program needs adjustment.

    Counterpoint: what about bodybuilders who die young? This is a legitimate objection that confuses muscle quantity with muscle quality. The association between muscle mass and longevity breaks down at extremes, particularly when extreme muscle mass is achieved through anabolic steroid use (which has direct cardiotoxic effects independent of muscle mass), extreme dietary manipulation (which can impair metabolic health), or when it coexists with visceral obesity (the “fat-fit” phenotype where muscle mass and organ fat coexist). The research on muscle and longevity is about natural muscle mass within a healthy metabolic context – not about competition-level bodybuilding. The protective effect of muscle is linear in the normal to moderately athletic range and plateaus, but does not reverse, at higher levels.

    Muscle is not an aesthetic asset. It is the single tissue that most directly determines whether you can stand, walk, carry groceries, travel independently, and live in your own home at 80. Treat it as infrastructure – something you build and maintain because the cost of replacement after failure is much higher than the cost of maintenance before it.

    The DEXA scan protocol. A DEXA scan provides total body lean mass, fat mass, bone mineral density, and regional breakdown (arms, legs, trunk, android/gynoid ratio). For muscle tracking, the metric to watch is appendicular lean mass index (ALMI): total lean mass of arms and legs divided by height in meters squared. Most people lose lean mass before they lose strength, and DEXA catches this decline before functional tests do. Baseline at 40, repeat every two years. If ALMI drops by more than 3% between scans, your training protein or training load needs adjustment. DEXA also captures bone mineral density, which declines in parallel with muscle mass and independently predicts fracture risk. One scan, two data streams.

    The financial argument for muscle. A hip fracture at 75 – the most common sarcopenia-related injury – carries a one-year mortality rate of approximately 20-30% and a permanent loss of independence rate of approximately 40-50%. The lifetime cost of a hip fracture (surgery, rehabilitation, home care, assisted living) exceeds $50,000 in direct costs and is incalculable in quality-of-life terms. The cost of maintaining muscle mass in your 40s and 50s is a gym membership ($30-50/month) and adequate protein intake ($1-2/day over baseline). The return on investment is not aesthetic. It is existential.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Celis-Morales CA, et al. "Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality." *BMJ*. 2018;361:k1651.. DOI: https://doi.org/10.1136/bmj.k1651

    [2] Srikanthan P, Karlamangla AS. "Muscle mass index as a predictor of longevity in older adults." *Am J Med*. 2014;127(6):547-553.. DOI: https://doi.org/10.1016/j.amjmed.2014.02.007

    [3] Burd NA, Gorissen SH, van Loon LJ. "Anabolic resistance of muscle protein synthesis with aging." *Exerc Sport Sci Rev*. 2013;41(3):169-173.. DOI: https://doi.org/10.1097/JES.0b013e318292f3d5

    [4] Cruz-Jentoft AJ, et al. "Sarcopenia: revised European consensus on definition and diagnosis." *Age Ageing*. 2019;48(1):16-31.. DOI: https://doi.org/10.1093/ageing/afy169

  • Grip Strength Is a Proxy for Something Deeper – and the Test That Measures That Thing Is More Useful

    Written by

    Unpaid Intern

    –

    Grip strength predicts all-cause mortality with remarkable consistency across populations, ages, and health statuses. The UK Biobank study of nearly 500,000 participants found that each 5 kg decrease in grip strength was associated with a 16% higher risk of all-cause mortality, and the association held after adjusting for age, BMI, smoking, physical activity levels, and socioeconomic status [1]. Meta-analyses have replicated the finding across dozens of cohorts worldwide. Grip strength is one of the most robust epidemiological predictors in the longevity literature.

    The common interpretation is that grip strength is somehow uniquely protective – that having strong hands extends your life. This is a category error.

    Grip strength predicts mortality because it correlates strongly with two things that actually matter: total body muscle mass and neuromuscular integrity [2]. A person with strong grip likely has good overall lean mass and a nervous system that can recruit muscle fibers effectively. The grip test is capturing the health of the entire motor system – the descending neural pathways, the motor unit recruitment efficiency, and the skeletal muscle mass that generates force. The hands are just the convenient measurement site.

    The neurological basis of this correlation is often overlooked. Grip strength depends on the motor cortex’s ability to activate alpha motor neurons, the transmission fidelity of the corticospinal tract, the neuromuscular junction’s functional integrity, and the muscle fibers’ contractile capacity. A declining grip strength reading is not a hand problem. It is a signal that one or more of these components is beginning to decline, often before the person notices any functional change. This is what makes grip strength valuable as a surveillance tool – it captures central nervous system aging that muscle mass alone does not reflect.

    This means grip-specific training – hand grippers, forearm curls, rock climbing, squeeze devices – does not improve your healthspan in any direct way. It improves your grip. And improved grip will show up as a better grip strength reading on the dynamometer, even though your overall muscle mass, neuromuscular health, and metabolic reserve may not have changed at all. The proxy improves without the underlying signal improving.

    This is not a critique of grip strength as a measure. It is a boundary condition on its interpretation. Grip strength is an excellent screening test – cheap, fast, and reproducible. It is a poor target for intervention. Training your grip to raise your grip strength is like raising your car’s oil pressure by tightening the oil cap. You changed the reading. You did not change the thing the reading measures.

    The real value of the annual grip test is as a compliance check. If your grip strength is dropping year over year, your overall training load is insufficient – you are losing muscle and neuromuscular function despite whatever exercise program you think you are doing. The test does not need to be replaced. It just needs to be interpreted as a proxy, not an endpoint.

    What should replace grip-specific training as a target? Functional tests that capture the same signal more directly. The five-times-sit-to-stand test (how quickly you can stand from a chair five times without using your arms) captures lower body strength, power, and neuromuscular coordination. Gait speed over 4 meters is a powerful predictor of falls, functional decline, and mortality. The Short Physical Performance Battery – which combines gait speed, chair stand, and balance – provides a composite picture of neuromuscular health that is more actionable than grip alone [3]. A person who can stand from a chair 10 times in 30 seconds is not at risk of functional decline regardless of their grip strength.

    Counterpoint: doesn’t grip training still build muscle in the forearm? Yes, locally. But the forearm muscle mass gained from grip training is approximately 200-300 grams in a dedicated program. The lean mass that predicts independence at 80 is the total muscle mass of the legs, back, chest, and shoulders – approximately 20-25 kg. Grip training adds a trivial amount to that total. The cost-benefit ratio of grip-specific training (time, effort, equipment) for the purpose of healthspan extension is extremely poor compared to compound resistance training targeting the major muscle groups.

    The Bettering Me recommendation: track grip strength annually as a dashboard light. If it is stable, your training program is adequate for maintenance. If it is rising, your training program is producing results. If it is declining, investigate – but do not train your grip. Check your lean mass (DEXA scan every two years), check your training consistency, check your protein intake, check your sleep. The grip test is a warning light, not a component. When the warning light flashes, do not check the light itself. Check the engine.

    The sit-to-stand alternative. If you can perform five chair stands (arms crossed over chest) in less than 10 seconds, your lower body strength and neuromuscular function are adequate for independence. If it takes more than 15 seconds, you are in the risk zone regardless of your grip strength. This test costs nothing, requires no equipment, and captures the signal that matters more directly than grip – because it is your legs, not your hands, that determine whether you can stand, walk, and climb at 80.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Celis-Morales CA, et al. "Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality." *BMJ*. 2018;361:k1651.. DOI: https://doi.org/10.1136/bmj.k1651

    [2] Cooper R, et al. "Objectively measured physical capability levels and mortality: systematic review and meta-analysis." *BMJ*. 2010;341:c4467.. DOI: https://doi.org/10.1136/bmj.c4467

    [3] Guralnik JM, et al. "Lower extremity function and subsequent disability." *J Gerontol*. 1994;49(2):M85-M94.. DOI: https://doi.org/10.1093/geronj/49.2.m85

  • There Are Only Three Blood Tests That Matter for Prevention. The Other Four Are Noise Until These Are Fixed

    Written by

    Unpaid Intern

    –

    The wellness industry has turned annual blood work into an anxiety generator. Lists of seven, ten, fourteen markers – each with an “optimal” range that shifts every time a supplement company publishes a blog post. The result is a population of people who are worried about their homocysteine while their cardiovascular ceiling is unknown, their metabolic trajectory is unchecked, and their inflammatory baseline is a guess.

    The Three Tests at a Glance

    • ApoB: Counts every atherogenic (plaque-forming) particle in circulation — a more accurate cardiovascular risk signal than standard LDL-C alone.
    • Fasting Insulin: Reveals insulin resistance years before fasting glucose rises, catching metabolic dysfunction at the earliest correctable stage.
    • hs-CRP: Measures chronic low-grade inflammation — the modifiable driver that accelerates atherosclerosis independent of lipid levels.

    The hierarchy of prevention blood work is not flat. It has three anchors, and everything else is a distraction until those three are addressed. These three markers form a tripod – each covers a domain no other test covers, and together they answer the three questions that determine whether your prevention strategy is working.

    ApoB is your cardiovascular ceiling. Apolipoprotein B counts every atherogenic particle in circulation – LDL, VLDL, IDL, and Lp(a) – because each of these particles carries exactly one ApoB molecule [1]. LDL-C, the standard metric, estimates the mass of cholesterol inside LDL particles. It does not count the particles themselves. The particles cause plaque, not the cholesterol inside them. ApoB tells you how many plaque-forming particles are circulating, regardless of how much cholesterol they happen to be carrying.

    This distinction matters because two people can have identical LDL-C while one has twice as many atherogenic particles. The person with many small dense LDL particles may have “normal” LDL-C (say, 110 mg/dL) but high ApoB (above 100 mg/dL), and their risk is higher than the person with the same LDL-C but low ApoB [2]. This discordance – the gap between what LDL-C says and what ApoB says – occurs in approximately 15-20% of the population. Those people are being misclassified by the standard panel.

    Fasting insulin is your metabolic trajectory. Fasting glucose is a late-stage indicator – by the time it rises above 100 mg/dL, your pancreatic beta cells have been compensating for years, secreting excess insulin to overcome reduced sensitivity [3]. A fasting glucose of 92 with a fasting insulin of 14 µIU/mL is not “normal.” It is a pancreas working triple shifts to keep the number flat. The threshold worth watching is insulin above 8-10 µIU/mL in the context of normal glucose. The simplest quantification is HOMA-IR: (fasting glucose × fasting insulin) ÷ 405. A value above 2.0 indicates insulin resistance. Above 2.5 signals significant metabolic dysfunction, even with pristine fasting glucose.

    hs-CRP is your inflammatory baseline. High-sensitivity C-reactive protein above 1 mg/L (and especially above 2 mg/L) signals a chronic low-grade inflammatory state that accelerates atherosclerosis independent of lipid levels [4]. The most common cause of elevated hs-CRP is visceral adiposity – fat tissue secretes IL-6, which stimulates hepatic CRP production. But it can also be driven by chronic infection (periodontal disease is a common hidden culprit), autoimmune conditions, or simply an inflammatory diet pattern. hs-CRP is modifiable: weight loss of 5-10% reliably drops it, as does consistent aerobic exercise, omega-3 intake, and eliminating ultra-processed foods. It is the cheapest, most telling measure of whether your lifestyle is producing a net anti-inflammatory effect.

    Homocysteine, vitamin D, thyroid panels, lipoprotein(a) – these matter, but they matter after the three anchors are known. A person with ApoB of 90 mg/dL, fasting insulin of 6 µIU/mL, and hs-CRP of 0.6 mg/L has more prevention information than someone who has all fourteen markers checked but none of these three. The “deep cuts” are for fine-tuning after the structural questions are answered.

    The exception is Lp(a) – lipoprotein(a) – which should be checked once in a lifetime because it is 80-90% genetically determined and does not respond to lifestyle [5]. But Lp(a) is not a substitute for ApoB. It is an additional risk modifier. Check Lp(a) once. If it is high, adjust your ApoB target downward (below 70 mg/dL instead of below 100). If it is low, never think about it again.

    The Bettering Me approach: fix the anchors first. Chase the edges only when the anchors are known and stable.

    The practical protocol for getting these tests. Most standard lab panels do not include ApoB or fasting insulin by default. You need to request them specifically. For ApoB: order “apolipoprotein B” (CPT 82172). For fasting insulin: order “insulin, fasting” (CPT 83525). For hs-CRP: order “C-reactive protein, high sensitivity” (CPT 86141). These three tests add approximately $60-90 to a standard blood draw if your insurance does not cover them. Direct-to-consumer labs like Quest and LabCorp offer them as individual add-ons. Life Extension, Marek Health, and several other direct-access providers offer prevention-focused panels that include all three.

    The retesting cadence. ApoB changes slowly – retest every 6-12 months unless you are on pharmacological therapy, in which case retest at 12 weeks post-initiation. Fasting insulin can change within 8-12 weeks of lifestyle intervention – retest at 12 weeks if you are making significant changes. hs-CRP is the most dynamic – it can shift within 4-6 weeks of weight loss, exercise adoption, or dietary change. A baseline measurement followed by a 12-week follow-up after intervention gives you a clear picture of whether your protocol is working.

    Your homocysteine is not going to kill you. Your ApoB, fasting insulin, and hs-CRP might – or might save you, depending on what you do with the information. Fix the anchors first. Then chase the edges.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Sniderman AD, et al. "A meta-analysis of LDL-C, non-HDL-C, and ApoB as markers of cardiovascular risk." *Circ Cardiovasc Qual Outcomes*. 2011;4(3):337-345.. DOI: https://doi.org/10.1161/CIRCOUTCOMES.110.959247

    [2] Otvos JD, et al. "Clinical implications of discordance between LDL-C and particle number." *J Clin Lipidol*. 2011;5(2):105-113.. DOI: https://doi.org/10.1016/j.jacl.2011.02.001

    [3] Kahn SE, Hull RL, Utzschneider KM. "Mechanisms linking obesity to insulin resistance and type 2 diabetes." *Nature*. 2006;444(7121):840-846.. DOI: https://doi.org/10.1038/nature05482

    [4] Ridker PM. "Clinical application of C-reactive protein for cardiovascular disease detection and prevention." *Circulation*. 2003;107(3):363-369.. DOI: https://doi.org/10.1161/01.CIR.0000053730.47739.3C

    [5] Kronenberg F. "Human Genetics and the Causal Role of Lipoprotein(a)." *Cardiovasc Drugs Ther*. 2016;30(1):87-100.. DOI: https://doi.org/10.1007/s10557-016-6648-3

  • The SPRINT MIND Result Is Real – But Your 128 Systolic Is Not the Same as Their 147

    Written by

    Unpaid Intern

    –

    The SPRINT MIND trial produced a genuinely important result: intensive blood pressure control (target below 120 mmHg systolic) reduced the risk of mild cognitive impairment and probable dementia by 19% compared to standard treatment (target below 140 mmHg) [1]. This is one of the few randomized controlled trials showing that a cardiovascular intervention directly reduces dementia risk. It is real, and it should change how clinicians and patients think about the relationship between blood pressure and brain health.

    But the trial’s population matters as much as its result. The average participant in SPRINT MIND was 68 years old with established hypertension – baseline systolic averaging 147 mmHg. Many had existing cardiovascular disease or chronic kidney disease [1]. The trial proved that dropping from 147 to 121 reduces dementia risk in older adults with hypertension. It did not prove that dropping from 125 to 115 does the same thing in a 45-year-old with no cardiovascular history.

    For a 45-year-old walking around with a systolic of 125, the clinical question is not “should I get below 120.” The question is: what is the trajectory?

    A person whose blood pressure has been 118 for a decade and is now trending 125 is not the same patient as someone whose blood pressure has been 145 for a decade and is now trending 125. One is climbing. The other is descending. The same absolute number means a different thing depending on the vector. This distinction is lost in the threshold-based model that guides most clinical decisions – you are either normotensive, prehypertensive, or hypertensive, and the treatment decision fires only when you cross the line.

    The longitudinal data from the Atherosclerosis Risk in Communities (ARIC) study shows that midlife blood pressure trajectories – not single readings – predict cognitive decline decades later [2]. Participants whose systolic rose from 110 to 130 between ages 45 and 55 had higher dementia risk than those whose systolic held steady at 120 across the same window, even though both groups had identical readings at age 55. The trajectory was the signal, not the absolute value.

    This matters because the J-curve hypothesis – the idea that lowering blood pressure too aggressively in certain populations may increase cardiovascular risk – has not been resolved for primary prevention in middle-aged adults [3]. SPRINT MIND’s intensive arm used a multi-drug protocol to achieve its 121 mmHg average. The same pharmacological approach applied to someone whose systolic is 125 and climbing might produce benefit, but the trial did not test that.

    There is also the question of mechanism. Blood pressure damages cerebral small vessels over years, not weeks. The cognitive decline that SPRINT MIND prevented was the result of cumulative microvascular damage in participants who had been hypertensive for decades. A 45-year-old whose pressure is 125 and steady has accumulated far less vascular damage than a 68-year-old whose pressure was 140+ for twenty years. The intervention window is wider. The urgency is lower. But the opportunity for primary prevention is real.

    The framework Bettering Me recommends is trajectory-based, not threshold-based. If your systolic has been within a 5-point band for five years, the intervention is behavioral maintenance: sleep consistency (blood pressure drops 10-20% during deep sleep – the nocturnal dip), sodium sensitivity awareness (test this by tracking pressure for two weeks on high vs low sodium), and aerobic volume above 150 minutes per week (each 1 MET increase in fitness is associated with approximately 5 mmHg lower systolic pressure) [4].

    If your systolic has risen more than 8 points in three years, the intervention is structural – even if you haven’t crossed a “hypertensive” threshold. That means a formal assessment: 24-hour ambulatory monitoring (office readings miss nocturnal hypertension, which is independently predictive of cardiovascular events), dietary sodium assessment, sleep apnea screening (OSA is a common secondary cause of rising pressure trajectories in midlife), and a discussion about pharmacological options if lifestyle alone is insufficient [5].

    The trajectory tells you whether you are approaching a ceiling or retreating from one. SPRINT MIND proved the ceiling matters for dementia. But for most people in their 40s, it is the slope – not the ceiling – that will decide whether they ever reach it.

    A practical note on nocturnal dipping. Blood pressure normally drops 10-20% during deep sleep – the “nocturnal dip.” People whose pressure does not dip (non-dippers) have higher cardiovascular and cognitive risk, independent of daytime readings [4]. The only way to know if you are a dipper is 24-hour ambulatory monitoring. If your office BP is 125/80 but your nocturnal average is 118/75, you are fine. If it is 125/80 and your nocturnal average is 120/78, you are a non-dipper, and your trajectory-based risk is higher than the office reading suggests. This is another reason the standard threshold-based approach misses the signal.

    The sodium sensitivity variable. Approximately 50% of people with normal blood pressure are sodium sensitive – their pressure rises measurably in response to high sodium intake. The others are sodium resistant. The only way to know which you are is to test it: 7-10 days of high sodium (add salt at every meal) vs 7-10 days of low sodium (eliminate added salt, avoid processed foods), measuring BP daily at the same time. If your systolic moves more than 5 mmHg between conditions, you are sodium sensitive, and sodium management is a structural intervention for you, not a marginal one.

    The threshold is a legal category. The trajectory is a clinical signal. Know which one you are looking at.

    Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

    References

    [1] Williamson JD, Pajewski NM, Auchus AP, et al. "Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial." *JAMA*. 2019;321(6):553-561.. DOI: https://doi.org/10.1001/jama.2018.21442

    [2] Gottesman RF, et al. "Midlife Hypertension and 20-Year Cognitive Change: The Atherosclerosis Risk in Communities Neurocognitive Study." *JAMA Neurology*. 2014;71(10):1218-1227.. DOI: https://doi.org/10.1001/jamaneurol.2014.1646

    [3] Bohm M, et al. "J-curve relation between achieved blood pressure and cardiovascular outcomes." *European Heart Journal*. 2010;31(16):1985-1992.. DOI: https://doi.org/10.1093/eurheartj/ehq156

    [4] Cornelissen VA, Smart NA. "Exercise training for blood pressure: a systematic review and meta-analysis." *J Am Heart Assoc*. 2013;2(1):e004473.. DOI: https://doi.org/10.1161/JAHA.112.004473

    [5] Sleep Apnea and BP Trajectory